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Patient Characteristics
Age (mean) 83.1 years	/ 10.1
Caucasians / African-Americans 84% / 16%
Gender % ( males / females ) 69 / 31






CKD ( IV/V) 46%
Prior CABG 28%
Co-morbidity based mortality Risk Scoring
STS – Mean Risk of Procedural Mortality 65%	/ 18.8 %
STS – mean Mortality or morbidity 87.1%	/ 23.7%









Results: All patients had uneventful BAVs with this form of Impella support.The
in-hospital mortality was 15% with mean hospital length of stay 6 days 	/ 3.
Conclusions: BAV supported by Impella LVAD in a group of high risk patients
with advanced age and poor cardiac reserve is feasible and efficacious.This
particular algorhythm permits intervention with only a single arterial access.
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Background: The approach of transcatheter aortic valve implantation (TAVI) is
primarily guided by the assessment of iliaco-femoral tract diameter. A minimal diameter
of 6mm of the transfemoral tract is required for transfemoral TAVI. Currently, projection
angiography (XA) and CT-angiography (CTA) are used interchangeably to evaluate
suitability of the iliaco-femoral tract. Discrepancies between XA and CTA remain to be
elucidated. We aim to reveal differences in iliaco-femoral tract diameters of TAVI
candidates assessed by XA and CTA.
Methods: Diameters of 273 prospectively collected iliacofemoral segments of 39 TAVI
candidates were analyzed on both XA and CTA by two observers. We determined the
interobserver agreement for both imaging modalities and the difference between XA and
CTA measurements.
Results: Diameters measured on CTA were on average smaller (mean 8.23.0 mm,
mean difference 1.89 mm [95%CI: 1.65-2.13mm; p0.001]). The interobserver agree-
ment was excellent (Pearson coefficient: 0.92 for XA and 0.93 for CTA). For 21% (8
patients) CTA based diameters would have resulted in withholding a transfemoral
procedure, whilst diameters measured on XA were larger than 6mm.
Conclusions: Diameters on CTA are significantly smaller than XA-based measurements,
which should be acknowledged when determining the TAVI approach. The cut-off value
of 6mm on XA may be lower for CTA.
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Background: We have previously shown that there is an increased rate of embolic cerebral
insults after transcatheter aortic valve implantation (TAVI). Cerebral microbleeds have been
identified as a marker for poor neurologic outcome. The aim of this study was to assess and
compare the rate of new periprocedural embolic cerebral insults and microbleeds in patients
after TAVI and surgical AVR by MRI and their respective clinical outcome.
Methods: 48 consecutive patients (18 male, 30 female, mean age 815 years, average log.
Euroscore 3210%) undergoing TAVI received a cranial MRI before and after the TAVI
procedure to detect new cerebral lesions. 44 consecutive patients (26 male, 18 female, mean
age 785 years, average log. Euroscore 1310%) undergoing surgical AVR also received a
baseline cerebral MRI scan preoperatively and MRI was repeated within 6 days after valve
implantation. MRI studies included axial diffusion weighted, T2 weighted, FLAIR-weighted
and T2 gradient echo sequences. Standardized clinical assessment of the neurologic status was
performed prior to aortic valve replacement and before discharge.
Results: In 63% of the TAVI patients new cerebral embolic lesions could be detected in the
postprocedural MRI. The maximal lesion size was  5mm in 10 patients,  10mm in 17
patients and 10mm in 3 patients. Despite the high incidence of morphologically detectable
lesions only a single patient developed relevant neurologic symptoms of a stroke. Within
patients after surgical AVR only 44% of the patients displayed new cerebral embolic lesions.
The maximal lesion size was 5mm in 10 patients, 10mm in 6 patients and 10mm in
3 patients. No clinically relevant strokes were seen in this group. In contrast, cerebral
microbleeds were only detected in 13% of the TAVI patients but in 64% of patients after
surgical AVR.
Conclusions: New embolic cerebral insults and microbleeds detected by MRI were seen
both patient groups (TAVI	surgical AVR). Patients after surgical AVR showed more
microbleeds, whereas patients after TAVI showed more embolic ischemic insults. However,
despite the high percentage of MRI detected lesions in both groups, relevant neurological
symptoms were very rare and mostly transitory.
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Background: The introduction of transcatheter aortic valve replacement (TAVR) has led
to a revival in balloon aortic valvuloplasty (BAV) as treatment for patients with severe
aortic stenosis.
Methods: A cohort of 472 patients underwent 538 BAV procedures. The cohort was
divided into two groups: Group I, 296 (55.0%) procedures before 2010 and Group II, 242
(45%) procedures after 2010. Successful BAV was defined as reduction 40% in the
mean gradient and/or increase in aortic valve area 40%. Clinical, hemodynamic, and
follow-up mortality data were collected.
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Results: The mean age in Group I was lower, 81.210.1 vs. 83.07.4 years, p0.02.
There was no difference between groups in Society of Thoracic Surgeons (STS) score
13.57.3 and 12.66.4, p0.1, and logistic EuroSCORE 45.421.9 vs. 45.722.4,
p0.9, or other co-morbidities. The mean increase in aortic valve area was 0.390.25 in
Group I vs. 0.370.26 in Group II, p0.46. BAV was unsuccessful in 35 (14.4%) in
Group I and in 46 (19.0%) in Group II, p0.18. Multivariable analysis (including time
period, balloon size, number inflation, aortic valve area, ejection fraction, repeat
procedure) detected repeated BAV procedures [HR 4.34 (95% CI 2.2-8.3), p 0.001] as
the strongest correlate for unsuccessful BAV. Serious vascular complications occurred
less in the latest period (2010 vs. 2010). (Table).
Conclusions: Recent improvements in technique and device have not led to higher
success in BAV procedures; but has led to a reduction in complication rates. Repeat BAV








Intra procedural death 6 (2) 5 (2) 0.97
Stroke 7 (2.3) 4 (1.6) 0.56
Tamponade 1 (0.33) 3 (1.2) 0.22
Coronary occlusion 2 (0.67) 0 0.2
Severe aortic regurgitation 4 (1.3) 2 (0.8) 0.56
Profound hypotension requiring
resuscitation and intubation or
cardioversion
5 (1.7) 3 (1.2) 0.66
Permanent pacemaker 4 (1.3) 3 (1.2) 0.9
Hemodialysis 2 (0.67) 1 (0.6) 0.68
Serious vascular complication
requiring intervention
24 (8.1) 10 (4.1) 0.05
Perforation 5 (1.7) 0 0.04
Ischemic leg 8 (2.7) 4 (1.6) 0.4
Pseudoaneurysm 10 (3.3) 4 (1.6) 0.2
Arterial-venous fistula 1 (0.33) 2 (0.8) 0.4
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Background: During a TAVI, the frame interacts with the native tissue and the
calcifications. It is generally accepted that these interactions lie at the basis of paravalvular
regurgitation and conduction problems. The objective of this pilot study is to examine an
image based analysis method for its capability to investigate these interactions, in order to
better understand the complication mechanisms.
Methods: 9 patients received a contrast enhanced, ECG triggered, diastolic, pre-
interventional and 7 days post-interventional CT scan at the University Hospital of
Antwerp (Belgium). The circumference and ellipticity of the annulus and the left
ventricular outflow track were measured in both pre and post datasets. The calcium on the
valve leaflets was reconstructed in 3D and separated before computing the volume. The
displacement was analyzed by measuring the distance between the centers of gravity and
the angle with respect to the basal attachment plane.
Results: Figure 1 depicts the calcium displacement in case 1. A correlation
between the change in geometry and the amount and distribution of calcium could
not be found. This might be due to the size of the dataset. Further research should
clarify this.
Conclusions: This pilot study demonstrates that 3D, computational image analysis can
provide additional insights in the complication mechanisms. From this data it can be
hypothesized that calcification motion is dependent on the location on the valve leaflets
and that calcium at the wall limits the deformation of the annulus. This hypothesis will be
checked through a study on a larger patient cohort.
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Background: Transcatheter aortic valve implantation (TAVI) is invariably associated
with the risk of clinically manifest transient or irreversible neurologic impairment. We
sought to investigate the incidence and causes of clinically manifest stroke during TAVI.
Methods: A total of 214 consecutive patients underwent TAVI with the Medtronic-
CoreValve System between November 2005 and September 2011 in our institution.
Stroke was defined by the Valve Academic Research Consortium recommendations. Its
cause was established by (i) analysing the time of onset of symptoms, (ii) correlating the
symptoms with computed tomography (CT) detected defects in the brain and (iii) by
analysing the presence of potential co-existing causes of stroke in addition to a
multivariable analysis to determine independent predictors.
Results: Stroke occurred in 19 patients (9%) and was major in 10 (5%), minor in 3 (1%)
and transient (TIA) in 6 (3%). The onset of symptoms was early (24 hours) in 8 patients
(42%) and delayed (24 hours) in 11 (58%). Brain CT scan showed a cortical infarct in
8 patients (42%; 6 territorial and 2 watershed), a lacunar infarct in 5 (26%), hemorrhage
in 1 (5%) but no abnormalities in 5 (26%). The time of onset of symptoms was not related
to the ischemic subtype except for watershed strokes (n2) which only occurred during
TAVI in the presence of severe sustained hypotension. Independent determinants of
stroke were new-onset atrial fibrillation after TAVI (OR: 4.4; 95% CI: 1.2-15.6) and
baseline aortic regurgitation grade III (OR: 3.2; 95% CI: 1.1-9.3).
Conclusions: The incidence of stroke was 9% of which more than half occurred 24
hours after the procedure. New-onset atrial fibrillation was associated with a 4.4-fold
increased risk of stroke. These findings indicate that improvements in postoperative care
after TAVI are equally if not more important for the reduction of periprocedural stroke
than preventive measures during the procedure.
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